Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Atara Biotherapeutics
Biotech
Atara, reeling from FDA hold on Ebvallo, halves workforce
Atara is halving its head count as it navigates the fallout from the FDA’s move to halt trials of Ebvallo and a CAR-T candidate.
James Waldron
Mar 4, 2025 8:07am
CRISPR-focused Caribou christens new CMO—Chutes & Ladders
Aug 16, 2024 8:30am
Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders
Feb 2, 2024 9:30am
After ph. 2 fail, Atara says goodbye to CMO and 25% of staff
Jan 31, 2024 11:22am
Atara's stock sinks as MS cell therapy fails in phase 2
Nov 9, 2023 6:50am
Beset by challenges, Atara lays off staff and slims R&D focus
Aug 9, 2022 10:31am
